Fibrosis reversal after hepatitis C virus elimination
Author:
- 1 May 2019
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Gastroenterology
- Vol. 35 (3) , 137-144
Abstract
Purpose of review Hepatitis C virus (HCV) infection has been the leading cause of cirrhosis in the United States now for the last several decades. With the introduction of highly effective direct acting antiviral (DAA) drugs, cure rates are now almost 100%. With this explosion of effective therapy, it is possible that many patients with HCV may have reversion in fibrosis. The purpose of this review is, therefore, to report on recent findings in this field. Recent findings Older data that examined the effect of interferon-based HCV therapy indicate that fibrosis reverses after HCV eradication. More recent work in the DAA era similarly indicates that fibrosis is reversible. A caveat is that DAA therapy causes rapid viral clearance, and appears to lead to rapid reductions in inflammation. Some tools (such as transient elastography), which may also reflect the inflammatory response, and thus may ‘overestimate’ of fibrosis reversal. However, emerging data suggesting improved outcomes in patients with cirrhosis after HCV clearance support the concept that even cirrhosis reverses in some patients. Summary Fibrosis (and cirrhosis) reversion, to some extent, occurs after HCV clearance. This topic is vitally important and information continues to emerge; more data on this subject are expected and needed.Keywords
This publication has 46 references indexed in Scilit:
- Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis CHepatology, 2017
- Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic FibrosisJAMA, 2012
- A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosisHepatology, 2012
- Adiponectin Regulation of Stellate Cell Activation via PPARγ-Dependent and -Independent MechanismsThe American Journal of Pathology, 2011
- Sustained Virologic Response Prevents the Development of Esophageal Varices in Compensated, Child-Pugh Class A Hepatitis C Virus–Induced Cirrhosis. A 12-Year Prospective Follow-Up StudyHepatology, 2010
- Fibrosis progression in chronic hepatitis CHepatology, 2009
- Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis #Hepatology, 2009
- Senescence of Activated Stellate Cells Limits Liver FibrosisCell, 2008
- Effects of endothelins on hepatic stellate cell synthesis of endothelin-1 during hepatic wound healingJournal of Cellular Physiology, 2002
- Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirrhosisGastroenterology, 1988